Biodefense Market By Product (Radiation/ Nuclear Defense, Anthrax, Botulism, Smallpox And Other Products) - Global Industry Analysis And Forecast To 2025
Biological attack is the intentional attack by viruses, bacteria and other germs that cause death or severe illness. These germs are present in the environment but their power is increased by to make the more harmful. These biological agents spread through ways like water, air or food. Biodefense makes use of medical measures to protecting the population against the biological attack. This includes steps like preparation & research and also vaccinations & medications against biological attack. Biodefense is the terms that mainly deals with bio-war or bioterrorism and includes the military or emergency response. The Biodefense mechanism is growing due to factors like; rising R&D related to the field, rising investment by various governments across the world for protecting people, technical advancement in various initiatives, etc. Therefore, the Biodefense Market is anticipated to expand and has tremendous scope during the forecast period. The global Biodefense Market anticipated to flourish in the future by growing at a significantly higher CAGR.
The global Biodefense Market is based on segment, by Product the market is segmented into Radiation/ Nuclear Defense, Anthrax, Botulism, Smallpox and Other Products. .
- Biodefense Market, By Product
- Radiation/ Nuclear Defense
- Other Products
On a global front, the Biodefense Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is dominating the Biodefense Market owing to higher number of government initiatives.
Biodefense Market, By Region
- North America
- Rest of Europe
- South Korea
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of MEA
The leading players in the market are Alnylam Pharmaceuticals Inc., Ichor Medical Systems, Xoma Corporation, Nanotherapeutics Inc., PharmAthene Inc., Achaogen Inc., Emergent BioSolutions Inc., Bavarian Nordic, Dynavax Technologies Corporation, Cleveland BioLabs, SIGA Technologies, DynPort Vaccine Company LLC and Elusys Therapeutics Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Alnylam Pharmaceuticals Inc.
- Ichor Medical Systems
- Xoma Corporation
- Nanotherapeutics Inc.
- PharmAthene Inc.
- Achaogen Inc.
- Emergent BioSolutions Inc.
- Bavarian Nordic
- Dynavax Technologies Corporation
- Cleveland BioLabs
- SIGA Technologies
- DynPort Vaccine Company LLC
- Elusys Therapeutics Inc.
Some of the key questions answered by the report are:
- What was the market size in 2014 and forecast from 2015 to 2025?
- What will be the industry market growth from 2015 to 2025?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?